Screener
NeoGenomics NEO Other operating expenses
Other operating expenses at other companies
Other financials
Where this comes from
Reported directly by NeoGenomics in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The source filing: NeoGenomics’s 10-Q, filed July 28, 2026.
- Filed
- Jul 28, 2026, 4:09 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001077183-26-000059
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Research and development | 10,761 | 9,023 | 20,295 | 19,204 |
| Sales and marketing | 27,275 | 24,075 | 51,105 | 46,758 |
| Impairment charges (Note 5) | — | 20,041 | — | 20,041 |
| Total operating expenses | 101,649 | 124,886 | 200,754 | 225,957 |
| LOSS FROM OPERATIONS | (9,771) | (47,628) | (28,012) | (75,453) |
| Interest income | 1,214 | 2,263 | 2,487 | 5,984 |
| Interest expense | (781) | (933) | (1,379) | (2,551) |
| Other (expense) income, net | (17) | 482 | (29) | 547 |
Item 1. Financial Statements (unaudited)
FAQ
- What is NeoGenomics's other operating expenses?
- NeoGenomics (NEO) reported other operating expenses of $101.65M in Q2 2026.
- How has NeoGenomics's other operating expenses changed year-over-year?
- NeoGenomics's other operating expenses decreased by 18.6% year-over-year, from $124.89M to $101.65M.
- What is the long-term trend for NeoGenomics's other operating expenses?
- Over 4 years (2021 to 2025), NeoGenomics's other operating expenses has grown at a 8.9% compound annual growth rate (CAGR), from $305.81M to $430.17M.
- What does other operating expenses mean?
- Residual operating expenses not classified into specific categories, serving as a catch-all for miscellaneous operating costs.
Ask your AI about NeoGenomics's other operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude